Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Systems integration partner

13 May 2005 07:01

Xaar PLC13 May 2005 FOR IMMEDIATE RELEASE 13 May 2005 Xaar plc IMPIKA APPOINTED AS SYSTEMS INTEGRATION PARTNER Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, and IMPIKA SA ("IMPIKA") of Aubagne, France are pleased to announce ajoint agreement for the provision of integration services for Xaar printheadsand other products. Under the agreement both parties will co-operate to provide complete turnkeysolutions for clients wishing to use Xaar technology for their productionprocesses, to open up new applications and create bespoke solutions. IMPIKA haslong experience with inkjet, including its application to the printing ofplastic and smart cards, packaging, labelling as well as special applicationsfor printing on CDs, glass and metal. Impika is also developing solutions basedon its material jetting technology for microelectronics and biomedicalapplications. Nigel Berry, Deputy CEO of Xaar commented: "I am very pleased to announce thisrelationship with IMPIKA. We previously stated our intention to partner with asmall number of high quality integrators which can offer existing and potentialusers of our technology a complete package of integration skills and bespokeequipment. We have known the team at IMPIKA for some time now and have beenimpressed by their standards and innovation. I look forward to working withthem on future projects." Paul Morgavi, IMPIKA'S CEO said: "Xaar is a great partner for us and we arealready forming strong links with their technical and marketing teams. There isa clear synergy between Xaar and Impika with both parties introducing newmarkets into the joint relationship. Last year we introduced our C9000 productbased on Xaar's Leopard printhead and we are working on various projects foradapting our IPS print engine to the next generation of Xaar printheads, likethe Omnidot and HSS. Full commercial release of these products is anticipatedlater this year or early next year." About Xaar Xaar plc is a market-leading inkjet technology company. It targets the world'sindustrial, commercial and office printing markets. The industrial andcommercial printing markets are targeted by Xaar's own range of inkjet productsin conjunction with partners and other key players in those markets; the officeprinting market is approached through Xaar's strong list of licensees.Additional information about Xaar is available at www.xaar.co.uk. About IMPIKA: Created in March 2003 as a spin-out from Gemplus, IMPIKA is headquartered atAubagne in the south of France. IMPIKA offers high-performance industrialprinting and material jetting solutions using inkjet technology; it currentlyhas 37 employees. IMPIKA designs, develops, implements and markets hardware and softwaresolutions, as well as the required engineering as regards ink and materialjetting, for industrial applications including digital printing,microelectronics and biotechnologies. Additional information about IMPIKA isavailable at www.impika.com. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive IMPIKA: +33 (0)4 42 62 43 00Paul Morgavi, CEO www.impika.com Bankside Consultants:Steve Liebmann 020-7444-4163 /07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding
21st Oct 20089:00 amRNSHolding(s) in Company
15th Oct 20087:00 amRNSInterim Management Statement
13th Oct 20084:41 pmRNSSecond Price Monitoring Extn
13th Oct 20084:36 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSNotice of IMS
5th Sep 200810:00 amRNSBlocklisting Interim Review -
5th Sep 20089:08 amRNSBlocklisting Interim Review
4th Sep 20089:00 amRNSHolding(s) in Company
3rd Sep 20084:14 pmRNSDirector/PDMR Shareholding
28th Aug 200810:27 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSHalf Yearly Report and Result
6th Aug 20087:00 amRNSNotice of Half Year Report
29th Jul 20089:39 amRNSHolding(s) in Company
25th Jul 20081:46 pmRNSHolding(s) in Company
15th Jul 200810:46 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSPeriod end update & new broke
5th Jun 20086:00 pmRNSTotal Voting Rights
30th May 20087:00 amRNSAnalyst/investor visit to Dru
23rd May 20087:00 amRNSChina business update: recent
15th May 20082:49 pmRNSHolding(s) in Company
14th May 200810:10 amRNSDirectorate Change
13th May 200812:04 pmRNSResult of AGM
13th May 200812:04 pmRNSResult of AGM
13th May 20086:00 amRNSInterim Management & AGM Stat
9th May 200811:48 amRNSTotal Voting Rights
29th Apr 20082:23 pmRNSDirector/PDMR Shareholding
28th Apr 20084:35 pmRNSHolding(s) in Company
28th Apr 20087:00 amRNSDrupa exhibition preview
10th Apr 20083:50 pmRNSAnnual Information Update
2nd Apr 20085:43 pmRNSTotal Voting Rights
27th Mar 20086:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.